Guidance Capital Inc. Has $458,000 Stake in Privia Health Group, Inc. (NASDAQ:PRVA)

Guidance Capital Inc. boosted its holdings in Privia Health Group, Inc. (NASDAQ:PRVA) by 7.7% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 25,663 shares of the company’s stock after purchasing an additional 1,835 shares during the quarter. Guidance Capital Inc.’s holdings in Privia Health Group were worth $458,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of PRVA. Sequoia Financial Advisors LLC lifted its stake in Privia Health Group by 2.3% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 26,246 shares of the company’s stock valued at $478,000 after acquiring an additional 583 shares in the last quarter. Benjamin F. Edwards & Company Inc. boosted its holdings in Privia Health Group by 8.5% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 7,695 shares of the company’s stock worth $134,000 after purchasing an additional 605 shares during the last quarter. Arizona State Retirement System boosted its holdings in Privia Health Group by 2.4% during the second quarter. Arizona State Retirement System now owns 26,574 shares of the company’s stock worth $462,000 after purchasing an additional 617 shares during the last quarter. Signaturefd LLC grew its position in Privia Health Group by 46.3% in the 2nd quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock worth $34,000 after purchasing an additional 626 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC lifted its position in shares of Privia Health Group by 9.2% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 8,970 shares of the company’s stock worth $176,000 after buying an additional 756 shares in the last quarter. Institutional investors and hedge funds own 94.48% of the company’s stock.

Insider Activity

In other Privia Health Group news, CEO Parth Mehrotra sold 135,142 shares of the stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $18.50, for a total value of $2,500,127.00. Following the completion of the transaction, the chief executive officer now owns 247,771 shares in the company, valued at approximately $4,583,763.50. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 14.20% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on PRVA. Royal Bank of Canada reiterated an “outperform” rating and set a $28.00 price target on shares of Privia Health Group in a report on Wednesday, August 14th. Evercore ISI reduced their price target on shares of Privia Health Group from $23.00 to $20.00 and set an “outperform” rating for the company in a research report on Tuesday, July 9th. KeyCorp began coverage on shares of Privia Health Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $23.00 target price on the stock. Finally, Robert W. Baird lifted their price target on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a report on Monday, August 26th. Two research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, Privia Health Group has an average rating of “Buy” and a consensus target price of $24.73.

Privia Health Group Stock Performance

PRVA traded down $0.06 on Wednesday, hitting $17.57. 91,659 shares of the company were exchanged, compared to its average volume of 854,859. Privia Health Group, Inc. has a 12 month low of $15.92 and a 12 month high of $24.35. The firm has a fifty day simple moving average of $18.75 and a two-hundred day simple moving average of $18.30. The stock has a market capitalization of $2.10 billion, a PE ratio of 117.53, a price-to-earnings-growth ratio of 4.05 and a beta of 0.76.

Privia Health Group (NASDAQ:PRVA) last announced its earnings results on Thursday, August 8th. The company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.02). Privia Health Group had a net margin of 0.88% and a return on equity of 2.42%. The business had revenue of $422.30 million for the quarter, compared to the consensus estimate of $411.50 million. During the same quarter in the prior year, the company earned $0.06 EPS. Privia Health Group’s revenue was up 2.2% compared to the same quarter last year. On average, equities analysts expect that Privia Health Group, Inc. will post 0.17 earnings per share for the current year.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.